GlaxoSmithKline Pharmaceuticals board to consider approval of unaudited financial results

25 Oct 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 11, 2013, to consider approval of unaudited financial results for the quarter ended September 30, 2013 (Q3).

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2543.10 33.80 (1.35%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×